Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$601M |
| 2 |
Parker-Hannifin
PH
|
+$576M |
| 3 |
JPMorgan Chase
JPM
|
+$575M |
| 4 |
Goldman Sachs
GS
|
+$452M |
| 5 |
FedEx
FDX
|
+$371M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$733M |
| 2 |
American Tower
AMT
|
+$684M |
| 3 |
Nike
NKE
|
+$601M |
| 4 |
AGN
Allergan plc
AGN
|
+$561M |
| 5 |
McDonald's
MCD
|
+$536M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 17.46% |
| 3 | Healthcare | 13.37% |
| 4 | Communication Services | 12.12% |
| 5 | Financials | 11.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KA
376
DELISTED
Kineta, Inc. Common Stock
KA
| $26.2M | 0.03% |
15,255
+6,474
| +74% | +$10.6M |
|
|
INVX
377
Innovex International
INVX
$1.79B
| $26M | 0.03% |
433,328
-112,186
| -21% | -$6.24M |
|
|
VTLE
378
DELISTED
Vital Energy
VTLE
| $25.5M | 0.03% |
90,317
-11,999
| -12% | -$3.3M |
|
379
AbbVie
ABBV
$465B
| $25.5M | 0.03% |
407,581
-1,904,692
| -82% | -$116M |
|
380
Clorox
CLX
$12.1B
| $25.3M | 0.03% |
+210,409
| New | +$24.8M |
|
381
Assembly Biosciences
ASMB
$507M
| $25.2M | 0.03% |
173,153
+3,983
| +2% | +$592K |
|
|
ZLTQ
382
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $25.2M | 0.03% |
579,074
+278,759
| +93% | +$11.2M |
|
|
SLCA
383
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $25.2M | 0.03% |
443,778
-26,285
| -6% | -$1.3M |
|
|
AET
384
CALL
DELISTED
Aetna Inc
AET
| $24.8M | 0.03% |
200,000
| – | – |
|
385
Mueller Water Products
MWA
$4.05B
| $24.8M | 0.03% |
1,861,373
-1,459,684
| -44% | -$18.7M |
|
386
Reliance Steel & Aluminium
RS
$21.2B
| $24.7M | 0.03% |
310,079
-176,779
| -36% | -$13.5M |
|
|
INN
387
Summit Hotel Properties
INN
$743M
| $24.6M | 0.03% |
1,532,160
-566,754
| -27% | -$7.94M |
|
388
Tenaris
TS
$28.1B
| $24.2M | 0.03% |
+678,431
| New | +$21.2M |
|
389
Plains GP Holdings
PAGP
$5.2B
| $24.2M | 0.03% |
697,400
+147,730
| +27% | +$5.06M |
|
|
AGU
390
DELISTED
Agrium
AGU
| $23.8M | 0.03% |
+237,349
| New | +$22.9M |
|
391
Renasant Corp
RNST
$4.05B
| $23.8M | 0.03% |
563,987
+149,217
| +36% | +$5.66M |
|
|
EPZM
392
DELISTED
Epizyme, Inc
EPZM
| $23.4M | 0.03% |
1,933,804
+184,069
| +11% | +$1.92M |
|
393
Fastenal
FAST
$55.2B
| $23.4M | 0.03% |
+1,990,452
| New | +$21.8M |
|
394
BHP
BHP
$213B
| $23.1M | 0.03% |
723,583
+714,704
| +8,049% | +$23.1M |
|
395
Constellium
CSTM
$3.96B
| $22.9M | 0.03% |
3,887,669
-577,042
| -13% | -$3.53M |
|
396
Philip Morris
PM
$312B
| $22.9M | 0.03% |
250,635
-1,096,040
| -81% | -$102M |
|
397
Dover
DOV
$27.4B
| $22.9M | 0.03% |
+378,731
| New | +$21.9M |
|
|
398
CALL
Biogen
BIIB
$30.4B
| $22.7M | 0.03% |
80,000
+60,000
| +300% | +$17.8M |
|
399
Veeva Systems
VEEV
$32.7B
| $22.5M | 0.03% |
551,968
-61,675
| -10% | -$2.52M |
|
|
ISBC
400
DELISTED
Investors Bancorp, Inc.
ISBC
| $22.1M | 0.02% |
1,587,258
-186,878
| -11% | -$2.44M |
|
Similar funds
Jennison Associates's Q4 2016 Portfolio in Review
As of Q4 2016, Jennison Associates held 857 positions worth $89.6B, down 3.4% from $92.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jennison Associates withdrew a net $3.76B in Q4 2016, closing 52 positions and reducing 313 holdings. Its most notable exit was lululemon athletica, an estimated $342M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Parker-Hannifin worth $606M.
- Jennison Associates's largest Q4 2016 buy was Parker-Hannifin: 4,330,276 shares worth $606M.
- Jennison Associates added most to Charter Communications in Q4 2016, an estimated $601M increase.
- Jennison Associates's biggest Q4 2016 reduction was Biogen, cutting an estimated $733M.
- Jennison Associates fully exited lululemon athletica in Q4 2016, selling an estimated $342M.
- Jennison Associates's ten largest holdings make up 25% of its $89.6B portfolio in Q4 2016.
- Jennison Associates opened 208 new positions and closed 52 in Q4 2016.
- Jennison Associates's portfolio value fell 3.4% quarter-over-quarter to $89.6B.
Based on Jennison Associates's 13F filing for Q4 2016, filed 6 Feb 2017.